| Peng, Peng |
NCT05469685: Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication |
|
|
| Completed | 4 | 914 | RoW | Vonoprazan, Amoxicillin | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 08/23 | 09/23 | | |
NCT05649540: Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori |
|
|
| Active, not recruiting | 4 | 900 | RoW | Vonoprazan, Amoxicillin | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 12/24 | 12/24 | | |
NCT04680598: Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study |
|
|
| Recruiting | N/A | 800 | RoW | ICI, Antiviral Prophylaxis | Sun Yat-sen University, Kaiping Central Hospital, Guangzhou No.12 People's Hospital, ZhongShan People 's Hospital | Hepatocellular Carcinoma | 12/23 | 12/23 | | |
NCT06037213: A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib |
|
|
| Recruiting | N/A | 500 | RoW | | Peking Union Medical College Hospital | Ovarian Cancer | 12/23 | 01/24 | | |
NCT05410015: Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer |
|
|
| Recruiting | N/A | 300 | RoW | Normal clinical treatment without intervention | Peking Union Medical College Hospital | Ovarian Cancer | 02/24 | 02/26 | | |
NCT05410028: New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence |
|
|
| Recruiting | N/A | 1000 | RoW | No intervention in clinical treatment | Peking Union Medical College Hospital | Ovarian Cancer | 03/24 | 03/26 | | |
